Reading Time: 3 minutesIntroduction Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been primarily recognized for its efficacy in managing type 2 diabetes and aiding in weight loss. However, recent studies have begun to explore its broader metabolic effects, particularly its influence on …